Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

419 ARTÍCULOS , VIENDO DEL 211 AL 225

Novel insights into the role of circular RNAs in Parkinson disease: An emerging renaissance in the management of neurodegenerative diseases

Dorostgou Z, Yadegar N, Dorostgou Z, Khorvash F, Vakili O.

J Neurosci Res. 2022 Sep;100(9):1775-1790. doi: 10.1002/jnr.25094. Epub 2022 May 31.

Human Brain-Based Models Provide a Powerful Tool for the Advancement of Parkinson's Disease Research and Therapeutic Development

McComish SF, MacMahon Copas AN, Caldwell MA.

Front Neurosci. 2022 May 16;16:851058. doi: 10.3389/fnins.2022.851058. eCollection 2022.

MALAT1 lncRNA and Parkinson's Disease: The role in the Pathophysiology and Significance for Diagnostic and Therapeutic Approaches

Abrishamdar M, Jalali MS, Rashno M.

Mol Neurobiol. 2022 Sep;59(9):5253-5262. doi: 10.1007/s12035-022-02899-z. Epub 2022 Jun 4.

Essential tremor plus rest tremor: current concepts and controversies

Erro R, Sorrentino C, Russo M, Barone P.

J Neural Transm (Vienna). 2022 Jul;129(7):835-846. doi: 10.1007/s00702-022-02516-2. Epub 2022 Jun 7.

Development of Unilateral Peri-Lead Edema Into Large Cystic Cavitation After Deep Brain Stimulation: A Case Report

Lu Y, Qiu C, Chang L, Luo B, Dong W, Zhang W, Sun HH.

Front Neurol. 2022 May 23;13:886188. doi: 10.3389/fneur.2022.886188. eCollection 2022.

Ketogenic therapy for Parkinson's disease: A systematic review and synthesis without meta-analysis of animal and human trials

Grammatikopoulou MG, Tousinas G, Balodimou C, Anastasilakis DA, Gkiouras K, Dardiotis E, Evangeliou AE, Bogdanos DP, Goulis DG.

Maturitas. 2022 Sep;163:46-61. doi: 10.1016/j.maturitas.2022.06.001. Epub 2022 Jun 9.

Neuroprotective approaches to halt Parkinson's disease progression

Sola P, Krishnamurthy PT, Kumari M, Byran G, Gangadharappa HV, Garikapati KK.

Neurochem Int. 2022 Sep;158:105380. doi: 10.1016/j.neuint.2022.105380. Epub 2022 Jun 17.

Beta-adrenergic drugs and risk of Parkinson's disease: A systematic review and meta-analysis

Singh A, Hussain S, Akkala S, Klugarová J, Pokorná A, Klugar M, Walters EH, Hopper I, Campbell JA, Taylor B, Antony B.

Ageing Res Rev. 2022 Sep;80:101670. doi: 10.1016/j.arr.2022.101670. Epub 2022 Jun 17.

Vitamin D Status and Parkinson's Disease

Barichella M, Garrì F, Caronni S, Bolliri C, Zocchi L, Macchione MC, Ferri V, Calandrella D, Pezzoli G.

Brain Sci. 2022 Jun 16;12(6):790. doi: 10.3390/brainsci12060790.

LRRK2 and Proteostasis in Parkinson's Disease

Pérez-Carrión MD, Posadas I, Solera J, Ceña V.

Int J Mol Sci. 2022 Jun 18;23(12):6808. doi: 10.3390/ijms23126808.

A review on pathology, mechanism, and therapy for cerebellum and tremor in Parkinson's disease

Zhong Y, Liu H, Liu G, Zhao L, Dai C, Liang Y, Du J, Zhou X, Mo L, Tan C, Tan X, Deng F, Liu X, Chen L.

NPJ Parkinsons Dis. 2022 Jun 24;8(1):82. doi: 10.1038/s41531-022-00347-2.

Connecting tremors - a circuits perspective

Buijink AWG, van Rootselaar AF, Helmich RC.

Curr Opin Neurol. 2022 Aug 1;35(4):518-524. doi: 10.1097/WCO.0000000000001071. Epub 2022 Jul 5.

Deep brain stimulation for Parkinson's disease-related postural abnormalities: a systematic review and meta-analysis

Spindler P, Alzoobi Y, Kühn AA, Faust K, Schneider GH, Vajkoczy P.

Neurosurg Rev. 2022 Oct;45(5):3083-3092. doi: 10.1007/s10143-022-01830-3. Epub 2022 Jul 5.

European Academy of Neurology/Movement Disorder Society - European Section guideline on the treatment of Parkinson's disease: I. Invasive therapies

Deuschl G, Antonini A, Costa J, Śmiłowska K, Berg D, Corvol JC, Fabbrini G, Ferreira J, Foltynie T, Mir P, Schrag A, Seppi K, Taba P, Ruzicka E, Selikhova M, Henschke N, Villanueva G, Moro E.

Eur J Neurol. 2022 Sep;29(9):2580-2595. doi: 10.1111/ene.15386. Epub 2022 Jul 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias